Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program ; volume:7 ; number:1 ; day:3 ; month:4 ; year:2019 ; pages:1-9 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (3.4.2019), 1-9, 12.2019
- Creator
-
Verzoni, Elena
Cartenì, Giacomo
Cortesi, Enrico
Giannarelli, Diana
Giglio, Andrea De
Sabbatini, Roberto
Buti, Sebastiano
Rossetti, Sabrina
Cognetti, Francesco
Rastelli, Francesca
Sobrero, Alberto
Turci, Daniele
Sternberg, Cora N.
Porta, Camillo
Cappuzzo, Federico
Tortora, Giampaolo
Tassinari, Davide
Panni, Stefano
Pazzola, Antonio
Surico, Gianmarco
Raimondi, Alessandra
Giorgi, Ugo De
Procopio, Giuseppe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0579-z
- URN
-
urn:nbn:de:101:1-2019042400474404348485
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Verzoni, Elena
- Cartenì, Giacomo
- Cortesi, Enrico
- Giannarelli, Diana
- Giglio, Andrea De
- Sabbatini, Roberto
- Buti, Sebastiano
- Rossetti, Sabrina
- Cognetti, Francesco
- Rastelli, Francesca
- Sobrero, Alberto
- Turci, Daniele
- Sternberg, Cora N.
- Porta, Camillo
- Cappuzzo, Federico
- Tortora, Giampaolo
- Tassinari, Davide
- Panni, Stefano
- Pazzola, Antonio
- Surico, Gianmarco
- Raimondi, Alessandra
- Giorgi, Ugo De
- Procopio, Giuseppe
- SpringerLink (Online service)
Other Objects (12)
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report
Renal Immune-Related Adverse Event Difficult to Diagnose during Nivolumab Treatment for Hypopharyngeal Carcinoma: Case Report
Brain connectivity extended and expanded
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report
Renal Immune-Related Adverse Event Difficult to Diagnose during Nivolumab Treatment for Hypopharyngeal Carcinoma: Case Report
Brain connectivity extended and expanded
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report
Renal Immune-Related Adverse Event Difficult to Diagnose during Nivolumab Treatment for Hypopharyngeal Carcinoma: Case Report
Brain connectivity extended and expanded
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report